ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Taiwan Liposome Company Ltd

Taiwan Liposome Company Ltd (TLC)

7.00
0.00
( 0.00% )
Updated: 11:00:00

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
7.00
Bid
6.66
Offer
7.10
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Previous Close
7.00
Open
-
Last Trade
Last Trade Time
-
Average Volume (3m)
-
Financial Volume
-
VWAP
-

TLC Latest News

Highlights of Dr. David Hunter’s Oral Presentation at ACR’s Late Breaking Abstracts Session

SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, Nov. 20, 2023 (GLOBE NEWSWIRE) -- Professor David Hunter, Florance and Cope Chair of Rheumatology at the University of Sydney, presented detailed...

TLC to Present Phase 3 Data of TLC599 in Late-Breaking Abstracts Session at ACR

SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, Nov. 08, 2023 (GLOBE NEWSWIRE) -- TLC BioSciences (TLC), a late clinical-stage specialty pharmaceutical company developing novel nanomedicines to...

TLC Announces TLC599 Agreement with Endo

SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, June 13, 2022 (GLOBE NEWSWIRE) -- TLC BioSciences (TLC), a clinical-stage specialty pharmaceutical company developing novel nanomedicines to...

TLC BioSciences Announces Publication of TLC599 Phase II Results in Arthritis Research & Therapy

SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, March 07, 2022 (GLOBE NEWSWIRE) -- TLC BioSciences, a clinical-stage specialty pharmaceutical company developing novel nanomedicines to target...

TLC Announces Voluntary Delisting and Deregistration of American Depositary Shares

This communication does not constitute an offer of any securities for sale or subscription or a solicitation of an offer to purchase or subscribe to any securities in any jurisdiction. The...

TLC Reports Second Quarter 2021 Financial Results and Provides Business Update

SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, Aug. 12, 2021 (GLOBE NEWSWIRE) -- TLC, a clinical-stage specialty pharmaceutical company developing novel nanomedicines to target areas of unmet...

TLC Announces Details of Stock Swap Transactions

TAIPEI, Taiwan, July 05, 2021 (GLOBE NEWSWIRE) -- Taiwan Liposome Company (Nasdaq: TLC, TWO: 4152, “the company”), a clinical-stage specialty pharmaceutical company developing novel...

TLC and Zydus Enter Agreement to Launch AmphoTLC™ in India

SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, May 26, 2021 (GLOBE NEWSWIRE) -- TLC (Nasdaq: TLC, TWO: 4152), a clinical-stage specialty pharmaceutical company developing novel nanomedicines to...

TLC Announces Approval of New Drug Application of Liposomal Amphotericin B in India

SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, May 25, 2021 (GLOBE NEWSWIRE) -- TLC (Nasdaq: TLC, TWO: 4152), a clinical-stage specialty pharmaceutical company developing novel nanomedicines to...

InspirMed Highlights Encouraging Data on ISPM21 and ISPM19 – Inhalable Liposome Formulations of Antiviral Drugs for COVID-1...

SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, May 23, 2021 (GLOBE NEWSWIRE) -- InspirMed Inc., a subsidiary of TLC (Nasdaq: TLC, TWO: 4152) that specializes in the development of proprietary...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000DR
40000000DR
120000000DR
260000000DR
520000000DR
1560000000DR
2600000000DR

TLC - Frequently Asked Questions (FAQ)

What is the current Taiwan Liposome share price?
The current share price of Taiwan Liposome is US$ 7.00
What is the 1 year trading range for Taiwan Liposome share price?
Taiwan Liposome has traded in the range of US$ 0.00 to US$ 0.00 during the past year

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
PRFXPainReform Ltd
US$ 10.47
(382.49%)
62.39M
XHGXChange TED Inc
US$ 2.511
(233.02%)
23.17M
NVNINVNI Group Ltd
US$ 1.90
(196.88%)
1.82M
BPTHBio Path Holdings Inc
US$ 1.95
(191.48%)
88.21M
APCXAppTech Payments Corporation
US$ 1.0701
(180.87%)
155.08M
LITMSnow Lake Resources Ltd
US$ 0.3394
(-58.58%)
49.5M
PLRZPolyrizon Ltd
US$ 2.0701
(-37.08%)
2.28M
MUUDirexion Daily MU Bull 2X Shares
US$ 15.56
(-36.59%)
1.05M
MULLGranite Shares 2x Long MU Daily ETF
US$ 13.90
(-36.44%)
241.71k
QUBTQuantum Computing Inc
US$ 17.131
(-33.29%)
67.97M
APCXAppTech Payments Corporation
US$ 1.0701
(180.87%)
155.08M
RGTIRigetti Computing Inc
US$ 8.08
(-24.42%)
94.58M
BPTHBio Path Holdings Inc
US$ 1.95
(191.48%)
88.21M
SOUNSoundHound AI Inc
US$ 18.6399
(-10.58%)
81.45M
NVDANVIDIA Corporation
US$ 131.26
(1.82%)
75.97M

TLC Discussion

View Posts
TraderStig TraderStig 3 years ago
#DDAmanda Chart on: $TLC

You can scan for these before they run.



#DDAmanda Promo Code: dsh888

What the Fact (Factor) Column is:

The Factor is a proprietary indicator used for scanning in #DDAmanda.

It's defined as Today's $Traded divided by the average daily $Traded (20 day avg).

SO, if a stock has say a 10 Factor that day, it means she traded 10 Times the $ she normally trades.

That's significant, and many times indicates that a run in the stock is coming.




👍️0
FROZENFLAME FROZENFLAME 4 years ago
$TLC READY FOR SOME NEWS .
👍️0
FROZENFLAME FROZENFLAME 4 years ago
$$$TLC$$$
👍️0
FROZENFLAME FROZENFLAME 4 years ago
https://ir.tlcbio.com/news-releases/news-release-details/tlc-announces-acceptance-manuscript-anti-covid-19-program
👍️0
FROZENFLAME FROZENFLAME 4 years ago
Nice close .
👍️0
FROZENFLAME FROZENFLAME 4 years ago
Hit me with the NEWS !!
👍️0
FROZENFLAME FROZENFLAME 4 years ago
4 weeks almost over, hydroxychloroquine. Study medication is administered through inhalation via a commercially available portable vibrating mesh nebulizer, and all subjects will be followed up for 4 weeks.
👍️0
FROZENFLAME FROZENFLAME 4 years ago
Adding .
👍️0
FROZENFLAME FROZENFLAME 4 years ago
This my baby, I’m adding more tomorrow .
👍️0
FROZENFLAME FROZENFLAME 4 years ago
https://ir.tlcbio.com/news-releases/news-release-details/tlc-announces-appointment-thomas-h-bliss-jr-mba-chief-business
👍️0
FROZENFLAME FROZENFLAME 4 years ago
Adding some more, updates coming soon .
👍️0
FROZENFLAME FROZENFLAME 4 years ago
O/S 5M one more update $10s will be up with no time .
👍️0
FROZENFLAME FROZENFLAME 4 years ago
https://finance.yahoo.com/news/tlc-enrolls-first-subject-phase-084100428.html
👍️0
FROZENFLAME FROZENFLAME 4 years ago
4K shares at $9.00 after hours !!!!
👍️0
FROZENFLAME FROZENFLAME 4 years ago
Huge potential !!!
👍️0
FROZENFLAME FROZENFLAME 4 years ago
Nice close .
👍️0
FROZENFLAME FROZENFLAME 4 years ago
I’m in $$$TLC$$$
👍️0
crudeoil24 crudeoil24 4 years ago

TLC Receives Australian and Taiwan Approval to Initiate Phase I Clinical Trial of TLC19 Inhalable Liposomal Hydroxychloroquine for COVID-19
👍️0
otcmoneydoubler otcmoneydoubler 4 years ago
TLC MOVING ON COVID AUSTRALIAN NEWS
👍️0

Your Recent History

Delayed Upgrade Clock